12
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Candida kruseirenal cyst infection and measurement of amphotericin B levels in cystic fluid in a patient receiving AmBisome®

, , , &
Pages 163-165 | Published online: 09 Jul 2009

References

  • Sklar AH, Caruana RJ, Lammers JE, et al. Renal infections in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1987; 10: 81–88.
  • Bennett WM. Evaluation and management of renal infection in patients with adult polycystic kidney disease. In: Grantham JJ, Gardner K Jr., eds. Proceedings of the First International Workshop on Polycystic Kidney Disease. Kansas City: Inter-collegiate Press, 1985: 98–105.
  • Samaranayake YH, Samaranayake LP. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J Med Microbiol 1994; 41: 295–310.
  • Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formula-tions of amphotericin B: clinical efficacy and toxicities. ClM Infect Dis 1998; 27: 603–618.
  • Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after bone marrow transplantation A prospective, randomized, double-blind study. J Infect Dis 1995; 171: 1545–1552.
  • Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplanta-tion and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274–1277.
  • Abbas J, Bodey GP, Hanna HA, et al. Candida krusei fungemia: an escalating serious infection in immunocompromised patients. Arch Intern Med 2000; 160: 2659–2664.
  • Muther RS, Bennett WM. Cyst fluid antibiotic concentration in polycystic kidney disease: difference between proximal and distal cysts. Kidney Int 1981; 20: 519–522.
  • Bennett WM, Elzinga L, Pulliam JP, et al. Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney dis-ease. Am J Kidney Dis 1985; 6: 400–404.
  • Alak A., Moy S, Bekersky I. A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphotericin B formulation. Ther Drug Monit 1996; 18: 604–609.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.